Skip to main content
OSCOTECInc. logo

OSCOTECInc. — Investor Relations & Filings

Ticker · 039200 ISIN · KR7039200001 KO Manufacturing
Open in API
Filings indexed 277 across all filing types
Latest filing 2019-04-04 Audit Report / Informat…
Country KR South Korea
Listing KO 039200

About OSCOTECInc.

https://oscotec.com/

Oscotec Inc. is a clinical-stage drug discovery and development company focused on translating scientific research into innovative medicines for clinically unmet needs. The company's development pipeline targets various diseases, with a primary focus on immunology, oncology, and neurodegenerative disorders. Key therapeutic areas include rheumatoid arthritis, immune thrombocytopenia, non-small cell lung cancer, acute myeloid leukemia, and Alzheimer's disease. Oscotec specializes in developing novel kinase inhibitors, such as Spleen Tyrosine Kinase (SYK) inhibitors, to address these conditions.

Recent filings

Filing Released Lang Actions
감사보고서 (2018.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for the company 'Oscotec' (주식회사 오스코텍). It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. It covers the fiscal year ending December 31, 2018. While it contains financial statements, it is specifically titled and structured as an Audit Report, which is a distinct category from a full Annual Report (10-K) or an Interim/Quarterly Report (IR). FY 2018
2019-04-04 Korean
연결감사보고서 (2018.12)
Interim / Quarterly Report Classification · 95% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Oscotec (오스코텍) for the fiscal year 2018. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. Since it contains full financial statements and audit opinions for a specific fiscal period, it is classified as an Interim/Quarterly Report (IR) in the context of our filing categories, as it represents the substantive financial reporting package. FY 2018
2019-04-04 Korean
사업보고서 (2018.12)
Interim / Quarterly Report Classification · 95% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Oscotec (오스코텍) for the fiscal year 2018. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. Since it contains full financial statements and audit opinions for a specific fiscal period, it is classified as an Interim/Quarterly Report (IR) in the context of our filing categories, as it represents the substantive financial reporting package. FY 2018
2019-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, board appointments, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports the outcome of shareholder votes at an AGM.
2019-03-28 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Oscotec. It contains the agenda for the 21st Annual General Meeting, including financial statement approval, board appointments, and remuneration limits. It also includes detailed management information (business overview, industry analysis, and market outlook) as required by Korean regulatory standards for shareholder meeting materials. This type of document is classified as a Proxy Solicitation & Information Statement (PSI) because it provides shareholders with the necessary information to vote on agenda items at the upcoming meeting.
2019-03-08 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by OscoTec. It contains the auditor's opinion (적정/Unqualified), financial highlights (assets, liabilities, equity, profit/loss), and details regarding the audit firm (인덕회계법인). While it provides financial data, it is a regulatory filing specifically announcing the submission of the audit report to the exchange, which falls under the category of Audit Report / Information (AR). FY 2018
2019-03-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.